| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/03/2011 | WO2010142906A3 Protein antigens for the serodiagnosis of staphylococcus aureus infections, in particular on osteoarticular prostheses |
| 03/03/2011 | WO2010141604A3 Combinatorial discovery of enzymes with utility in biomass transformation |
| 03/03/2011 | WO2010136548A3 Fibrosuppressant biotherapeutics |
| 03/03/2011 | WO2010129609A3 Antibodies and methods of use thereof |
| 03/03/2011 | WO2010129265A3 Compositions comprising monomeric streptavidin and methods for using same |
| 03/03/2011 | WO2010127119A3 Multiphasic microfibers for spatially guided cell growth |
| 03/03/2011 | WO2010124226A3 Toll-like receptor-based biosensors |
| 03/03/2011 | WO2010123290A3 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same |
| 03/03/2011 | WO2010118347A3 O-linked glycan biosynthesis modulators |
| 03/03/2011 | WO2010115089A3 Serial multiple antigen colocalization in paraffin-embedded tissue |
| 03/03/2011 | WO2010111421A3 Isoform nell-1 peptide |
| 03/03/2011 | WO2010104357A3 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 03/03/2011 | WO2010101793A3 Methods and compositions for the diagnosis, prognosis and treatment of cancer |
| 03/03/2011 | WO2010101526A9 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof |
| 03/03/2011 | WO2010065479A9 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury |
| 03/03/2011 | WO2009002931A3 Methods and uses thereof of prosaposin |
| 03/03/2011 | WO2008152447A3 Staphylococcus aureus specific anti-infectives |
| 03/03/2011 | US20110055979 Protein Kinase Stress-Related Proteins and Methods of Use in Plants |
| 03/03/2011 | US20110055972 Sugar and lipid metabolism regulators in plants iv |
| 03/03/2011 | US20110055971 Sugar and lipid metabolism regulators in plants iii |
| 03/03/2011 | US20110055968 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 03/03/2011 | US20110055964 Method for Generating Hypermutable Plants |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110055940 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use |
| 03/03/2011 | US20110054442 Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease |
| 03/03/2011 | US20110054165 Xanthene dyes |
| 03/03/2011 | US20110054160 Therapeutic compositions |
| 03/03/2011 | US20110054158 Polynucleotides encoding class ii cytokine receptor-7 |
| 03/03/2011 | US20110054152 Hydroxyalkyl Starch Derivatives |
| 03/03/2011 | US20110054149 NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases |
| 03/03/2011 | US20110054148 Antibodies to interferon-like protein zcyto21(il-29) |
| 03/03/2011 | US20110054147 Molecular weight markers for membrane proteins |
| 03/03/2011 | US20110054146 Preparation of Low Molecular Weight Polylysine and Polyornithine in High Yield |
| 03/03/2011 | US20110053865 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| 03/03/2011 | US20110053863 Methods of using flt3-ligand in the treatment of cancer |
| 03/03/2011 | US20110053850 Doc1 compositions and methods for treating cancer |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 03/03/2011 | US20110053848 Prodrug comprising a drug linker conjugate |
| 03/03/2011 | US20110053843 E-selectin compositions and use thereof for inducing e-selectin tolerance |
| 03/03/2011 | US20110053842 Targeted therapeutics based on engineered proteins that bind egfr |
| 03/03/2011 | US20110053841 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 03/03/2011 | US20110053839 GLP-1 Derivatives II |
| 03/03/2011 | US20110053838 Process for solubilizing glucagon-like peptide 1 compounds |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110053829 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 03/03/2011 | US20110053827 Intranasal administration |
| 03/03/2011 | US20110053796 Modified stefin a scaffold proteins |
| 03/03/2011 | US20110053787 Compositions and Methods of Detecting Post-Stop Peptides |
| 03/03/2011 | US20110053781 Methods and compositions for polypeptide engineering |
| 03/03/2011 | US20110053292 signal amplification technique for mass analysis |
| 03/03/2011 | US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110053249 Adenoviruses Mutated In The VA Genes For Cancer Treatment |
| 03/03/2011 | US20110053244 NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS |
| 03/03/2011 | US20110053221 Recombinant production of authentic human proteins using human cell expression systems |
| 03/03/2011 | US20110053220 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053214 Production of galactosylated glycoproteins in lower eukaryotes |
| 03/03/2011 | US20110053189 Type IV secretion system proteins in sero-detection of Anaplasma phagocytophium |
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/03/2011 | US20110053177 Mass spectrometric methods and products |
| 03/03/2011 | US20110053156 Small cell lung carcinoma biomarker panel |
| 03/03/2011 | US20110053154 2'-nitrobenzyl-modified ribonucleotides |
| 03/03/2011 | US20110053148 Coccidiosis vaccines |
| 03/03/2011 | US20110053137 Methods of modulating cold sensory perception |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 03/03/2011 | US20110052639 Allergen mutants |
| 03/03/2011 | US20110052638 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052628 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 03/03/2011 | US20110052624 Type 5 And Type 8 Capsular Polysaccharides Of Overproducing S. Aureus Strains |
| 03/03/2011 | US20110052620 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 03/03/2011 | US20110052618 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052607 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 03/03/2011 | US20110052591 Variants of Thyroid Stimulating Hormone Beta |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052588 Method of treating hepatocellular carcinoma |
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
| 03/03/2011 | US20110052577 Antibodies |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | US20110052514 Use of natural active substances in cosmetic or therapeutic compositions |
| 03/03/2011 | US20110052508 Peptide-based oral care surface reagents for personal care |
| 03/03/2011 | US20110052507 Oral care compositions comprising casein, ovalbumin, whey or soy protein |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | US20110052499 Baboon homolog of human cd147 |
| 03/03/2011 | US20110052496 Hollow nanoparticles and uses thereof |
| 03/03/2011 | US20110052494 H-antigen binding polypeptides and methods of use |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | DE202005021885U1 Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt A hydroxyalkyl starch protein conjugates prepared by reductive amination |
| 03/03/2011 | DE102007004283B4 Magnetresonanz-Kontrastmittel mit eisenbindendem Protein Magnetic resonance contrast agent with eisenbindendem protein |
| 03/03/2011 | CA2809803A1 Stabilized melanocortin ligands |
| 03/03/2011 | CA2772654A1 Polynucleotides derived from chickpea and uses thereof |
| 03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/03/2011 | CA2772224A1 Complete genome sequence of the methanogen methanobrevibacter ruminantium |